# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 172


After regulation 214 (amendment of regulation 293 (prohibition of supply to the public for promotional purposes) insert—
“Amendment of regulation 294 (general requirements)
214A. In regulation 294, after paragraph (4) insert—
“(5) In the case of an advertisement which relates to a medicinal product for sale or supply—
(a) in Northern Ireland only, the requirements of this regulation must be met in relation to the product for sale or supply in Northern Ireland,
(b) in Great Britain only, the requirements of this regulation must be met in relation to the product for sale or supply in Great Britain, and
(c) in the whole of the United Kingdom, the requirements of this regulation must be met in relation to both—
(i) the product for sale or supply in Great Britain, and
(ii) the product for sale or supply in Northern Ireland.”.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/172 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-172
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.